Legend Biotech (LEGN) Income towards Parent Company (2019 - 2025)

Legend Biotech has reported Income towards Parent Company for 7 years, with the latest figure at $30.8 million in Q4 2025.

• For the quarter ending Q4 2025, Income towards Parent Company rose 117081.56% year-over-year to $30.8 million; the trailing twelve-month figure through Dec 2025 stood at -$232.8 million (up 39.41% YoY), and the FY2025 full-year result was -$268.4 million, down 151516.15% from the prior year.
• Income towards Parent Company for Q4 2025 stood at $30.8 million, up from -$38.5 million in the prior quarter.
• The five-year high for Income towards Parent Company was $30.8 million in Q4 2025, with the low at -$199.1 million in Q2 2023.
• Historically, Income towards Parent Company has averaged -$87.1 million across 5 years, with a median of -$90.0 million in 2021.
• Annual changes were most pronounced in 2022 — Income towards Parent Company slumped 35570.18% — and 2025, when it surged 117081.56%.
• Legend Biotech's Income towards Parent Company stood at -$88.3 million in 2021, then sank by 53.82% to -$135.9 million in 2022, then surged by 99.89% to -$144818.0 in 2023, then jumped by 118.15% to $26284.0 in 2024, then surged by 117081.56% to $30.8 million in 2025.
• The last three Income towards Parent Company figures came in at $30.8 million (Q4 2025), -$38.5 million (Q3 2025), and -$124.2 million (Q2 2025), per Business Quant data.